A detailed history of Mariner, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Mariner, LLC holds 13,650 shares of CYBN stock, worth $120,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,650
Previous 13,650 -0.0%
Holding current value
$120,666
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.38 - $0.65 $440 - $753
-1,159 Reduced 7.83%
13,650 $5,000
Q3 2023

Nov 13, 2023

SELL
$0.29 - $0.63 $1,874 - $4,071
-6,463 Reduced 30.38%
14,809 $7,000
Q1 2023

May 12, 2023

SELL
$0.3 - $0.56 $276 - $515
-921 Reduced 4.15%
21,272 $8,000
Q3 2022

Nov 10, 2022

BUY
$0.48 - $1.11 $10,652 - $24,634
22,193 New
22,193 $11,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $1.47B
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.